Literature DB >> 22717061

Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study.

Y S Kim1, D S Han, Y H Kim, W H Kim, J S Kim, H S Kim, H S Kim, Y S Park, H J Song, S J Shin, S K Yang, B D Ye, C S Eun, K M Lee, S H Lee, B I Jang, S A Jung, J H Cheon, C H Choi, K C Huh.   

Abstract

The incidence and severity of Clostridium difficile infections (CDI) have increased in Western countries. However, there are limited data regarding the epidemiology of CDI in Eastern countries. This nationwide study was conducted in 17 hospitals to determine temporal trends in CDI incidence (from 2004 to 2008) in South Korea. The total incidence of CDI in Korea was 1·7 cases/1000 adult admissions in 2004, and 2·7/1000 cases in 2008 (P = 0·028). When analysing the clinical features of 1367 CDI patients diagnosed in 2008, oral metronidazole was effective as a first-line treatment for CDI (61·9%). Relapse rate was 8·9% and complicated CDI was only observed in 3·6%. The incidence of CDI increased significantly in Korea from 2004 to 2008. Although the clinical features were milder than in Western countries, the increasing burden of CDI needs ongoing surveillance systems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717061      PMCID: PMC9152062          DOI: 10.1017/S0950268812000581

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  29 in total

1.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  [Change of Clostridium difficile colitis during recent 10 years in Korea].

Authors:  Yune Jeong Lee; Myung Gyu Choi; Chul Hyun Lim; Woong Ryong Jung; Hyun Sun Cho; Hye Young Sung; Kwan Woo Nam; Jae Hyuck Chang; Yu Kyung Cho; Jae Myung Park; Sang Woo Kim; In Sik Chung
Journal:  Korean J Gastroenterol       Date:  2010-03

3.  Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals.

Authors:  Mark A Miller; Meagan Hyland; Marianna Ofner-Agostini; Marie Gourdeau; Magued Ishak
Journal:  Infect Control Hosp Epidemiol       Date:  2002-03       Impact factor: 3.254

4.  [The incidence and clinical features of Clostridium difficile infection; single center study].

Authors:  Jin Ho Lee; Su-Yeon Lee; You Sun Kim; Sun-Wook Park; Sung Won Park; So Young Jo; Soo Hyung Ryu; Jung Hwan Lee; Jeong Seop Moon; Dong Hee Whang; Bo Moon Shin
Journal:  Korean J Gastroenterol       Date:  2010-03

5.  Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.

Authors:  Jacques Pepin; Marie-Eve Alary; Louis Valiquette; Evelyne Raiche; Joannie Ruel; Katalin Fulop; Dominique Godin; Claude Bourassa
Journal:  Clin Infect Dis       Date:  2005-04-25       Impact factor: 9.079

6.  Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.

Authors:  Lorraine Kyne; Mary Beth Hamel; Rajashekhar Polavaram; Ciarán P Kelly
Journal:  Clin Infect Dis       Date:  2001-12-17       Impact factor: 9.079

7.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

8.  Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005.

Authors:  Bo-Moon Shin; Eun Young Kuak; Hyeon Mi Yoo; Eui Chong Kim; Kyungwon Lee; Jung-Oak Kang; Dong Hee Whang; Jeong-Hwan Shin
Journal:  J Med Microbiol       Date:  2008-06       Impact factor: 2.472

9.  A European survey of diagnostic methods and testing protocols for Clostridium difficile.

Authors:  F Barbut; M Delmée; J S Brazier; J C Petit; I R Poxton; M Rupnik; V Lalande; C Schneider; P Mastrantonio; R Alonso; E Kuipjer; M Tvede
Journal:  Clin Microbiol Infect       Date:  2003-10       Impact factor: 8.067

10.  Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.

Authors:  Denise Gravel; Mark Miller; Andrew Simor; Geoffrey Taylor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly; David Boyd; Michael Mulvey
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

View more
  24 in total

Review 1.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

2.  Bile salt hydrolase-mediated inhibitory effect of Bacteroides ovatus on growth of Clostridium difficile.

Authors:  Soobin Yoon; Junsun Yu; Andrea McDowell; Sung Ho Kim; Hyun Ju You; GwangPyo Ko
Journal:  J Microbiol       Date:  2017-10-27       Impact factor: 3.422

3.  Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland.

Authors:  J Czepiel; J Kędzierska; G Biesiada; M Birczyńska; W Perucki; P Nowak; A Garlicki
Journal:  Epidemiol Infect       Date:  2015-04-10       Impact factor: 4.434

4.  To the Editor: Molecular epidemiology of toxigenic Clostridium difficile isolates in Korea.

Authors:  S Y Cho; Y Nam; Y S Soh; T S Park; H J Lee
Journal:  Epidemiol Infect       Date:  2013-12-02       Impact factor: 4.434

5.  Refractory Clostridium difficile Infection Cured With Fecal Microbiota Transplantation in Vancomycin-Resistant Enterococcus Colonized Patient.

Authors:  Mi-Ok Jang; Jun Hwan An; Sook-In Jung; Kyung-Hwa Park
Journal:  Intest Res       Date:  2015-01-29

6.  What's the Clinical Features of Colitis in Elderly People in Long-Term Care Facilities?

Authors:  So Yoon Yoon; Sung-Ae Jung; Sun-Kyung Na; Jae-In Ryu; Hye-Won Yun; Min-Jin Lee; Eun-Mi Song; Seong-Eun Kim; Hye-Kyung Jung; Ki-Nam Shim
Journal:  Intest Res       Date:  2015-04-27

7.  Risk Factors for Delayed Recurrence of Clostridium difficile Infection.

Authors:  Ji Won Kim
Journal:  Intest Res       Date:  2014-10-27

8.  Epidemiology of Clostridium difficile infection in Asia.

Authors:  Deirdre A Collins; Peter M Hawkey; Thomas V Riley
Journal:  Antimicrob Resist Infect Control       Date:  2013-07-01       Impact factor: 4.887

Review 9.  Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review.

Authors:  Eroboghene H Otete; Anand S Ahankari; Helen Jones; Kirsty J Bolton; Caroline W Jordan; Tim C Boswell; Mark H Wilcox; Neil M Ferguson; Charles R Beck; Richard L Puleston
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

Review 10.  Clostridium difficile infection: a worldwide disease.

Authors:  Kristin E Burke; J Thomas Lamont
Journal:  Gut Liver       Date:  2014-01-13       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.